Health TrialsbyHealthPanel

Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations

1

Review clinical trials related to Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

The purpose of this study is to evaluate the safety, efficacy and pharmacokinetics (PK) of zipalertinib in participants with locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) harboring EGFR ex20ins mutations and other mutations.

Participants needed: 220
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Taiho Oncology, Inc.Updated: Oct 6, 2026Locations: 80
Eligibility criteria

Written informed consent. [+37]

Participant is currently receiving an investigational drug in a clinical trial o... [+22]

Read more